Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.68 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | CNR2 | P34972 | 1/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | TERT | O14746 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28100380 | 1.00 | FAAH (0.68) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL1702128 | 0.94 | FAAH (0.60) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL19064299 | 0.92 | FAAH (0.62) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Carbamic Acid SCHEMBL27418030 | 0.90 | FAAH (0.68) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL27418061 | 0.90 | FAAH (0.79) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL540383 | 0.89 | TERT (0.66) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2788686 | 0.89 | TERT (0.66) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL422846 | 0.89 | TERT (0.66) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL9517250 | 0.89 | TERT (0.66) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10488884 | 0.89 | TERT (0.66) | FAAHSOAT1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12521342-B2 | Fast disintegrating tablet | CUBOPHARM PTY LTD (AU) | 2026-01-13 | — | — | US | disclosed |
| US-12521350-B2 | Liquid crystalline dosage form for administering a statin | CUBOPHARM PTY LTD (AU) | 2026-01-13 | — | — | US | disclosed |
| US-20240366510-A1 | LIQUID CRYSTALLINE DOSAGE FORM FOR ADMINISTERING A STATIN | ZEENAR ENTERPRISES PTY LTD (AU) | 2024-11-07 | — | — | US | disclosed |
| US-20240350405-A1 | FAST DISINTEGRATING TABLET | ZEENAR ENTERPRISES PTY LTD (AU) | 2024-10-24 | — | — | US | disclosed |
| WO-2023210218-A1 | LUBRICATING OIL COMPOSITION | ＥＮＥＯＳ株式会社 | 2023-11-02 | — | — | WO | disclosed |
| US-20230277463-A1 | LIQUID CRYSTALLINE DOSAGE FORM FOR ADMINISTERING A STATIN | ZEENAR ENTERPRISES PTY LTD (AU) | 2023-09-07 | — | — | US | disclosed |
| US-11638698-B2 | Liquid crystalline dosage form for administering a statin | ZEENAR ENTERPRISES PTY LTD (AU) | 2023-05-02 | — | — | US | disclosed |
| CN-112912477-B | Lubricating oil composition | 引能仕株式会社 | 2022-11-11 | — | — | CN | disclosed |
| CN-112912478-B | Lubricating oil composition | 引能仕株式会社 | 2022-11-08 | — | — | CN | disclosed |
| US-20210369623-A1 | COMPOSITION THAT FORMS LIQUID CRYSTALLINE PARTICLES | ZEENAR ENTERPRISES PTY LTD (AU) | 2021-12-02 | — | — | US | disclosed |
| US-7871966-B2 | Lubricating oil composition | NIPPON OIL CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| CN-101883839-A | lubricating oil composition | NIPPON OIL CORP | 2010-11-10 | — | — | CN | disclosed |
| CN-101883840-A | lubricating oil composition | NIPPON OIL CORP | 2010-11-10 | — | — | CN | disclosed |
| CN-101855295-A | Process for production of molded polyester resin article, crystallization inducer for use in the process, master batch, and molded polyester resin article | DAINICHISEIKA COLOR CHEM | 2010-10-06 | — | — | CN | disclosed |
| US-20090075852-A1 | Low Ash Engine Oil Composition | NIPPON OIL CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| EP-1997871-A1 | LOW-ASH ENGINE OIL COMPOSITION | Nippon Oil Corporation (JP) | 2008-12-03 | — | — | EP | disclosed |
| US-20080234153-A1 | LUBRICATING OIL COMPOSITION | NIPPON OIL CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20060172900-A1 | LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION | NIPPON OIL CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1686167-A1 | LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION | Nippon Oil Corporation (JP) | 2006-08-02 | — | — | EP | disclosed |
| US-5358652-A | Using 3,5-dihydrocarbyl-4-hydroxybenzylamine compound | ETHYL PETROLEUM ADDITIVES, LIMITED (GB) | 1994-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366510-A1 | LIQUID CRYSTALLINE DOSAGE FORM FOR ADMINISTERING A STATIN | HMGCR, LIPA, NPC1L1 | FAAH 3027/4885SOAT1 172/4885CYP1A2 453/4885 |
| US-20230277463-A1 | LIQUID CRYSTALLINE DOSAGE FORM FOR ADMINISTERING A STATIN | HMGCR, LIPA, NPC1L1 | FAAH 3027/4885SOAT1 172/4885CYP1A2 453/4885 |
| US-20210369623-A1 | COMPOSITION THAT FORMS LIQUID CRYSTALLINE PARTICLES | AQP1, OSTC, AQP3 | FAAH 2162/4885SOAT1 58/4885CYP1A2 1358/4885 |
| US-11638698-B2 | Liquid crystalline dosage form for administering a statin | HMGCR, LIPA, NPC1L1 | FAAH 3027/4885SOAT1 172/4885CYP1A2 453/4885 |
| US-20240350405-A1 | FAST DISINTEGRATING TABLET | SI, DSC1, STOM | FAAH 2990/4885SOAT1 2897/4885CYP1A2 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.